NIH investigates a serious side effect from a COVID-19 vaccine trial; a report says the pandemic has erased 25 years' worth of global health gains; the US seeks to extend a ban on global health aid for foreign organizations that provide or promote abortions.
Reported by Kaiser Health News, the NIH has launched an investigation into a serious side effect stemming from the coronavirus disease 2019 (COVID-19) vaccine trial by AstraZeneca, in which a participant suffered spinal cord damage. AstraZeneca has not confirmed what the participant was afflicted with, but neurologists consider the side effect to be transverse myelitis, a disorder that produces inflammation along the spinal cord. The FDA is weighing whether to resume the halted trial.
The Bill and Melinda Gates Foundation said the pandemic has set global health back 25 years when looking at metrics such as childhood vaccinations, rising food insecurity, and levels of poverty. The organization's annual Goalkeepers report said most of the 18 metrics tracked by the United Nation's Sustainable Development Goals have regressed.
The Trump administration is seeking to extend a ban on global health aid for foreign organizations that provide or promote abortions, according to The Hill. Called the “global gag rule” by opponents, the ban already applies to grants and cooperative agreements between the US government and foreign organizations, but the proposed rule extension would expand the policy to contracts, where foreign groups would be required to not provide or promote abortions to maintain global health aid. According to Kaiser Family Foundation, contracts contribute approximately 40% of global health aid.
The study found significant disparities in the exposure to contaminants. Communities with higher percentages of Hispanic and Black residents were not only more likely to have unregulated chemicals in their drinking water, but they were also more frequently located near pollution sources.
Read More
Frameworks for Advancing Health Equity: Trans and Gender Diverse Health Care
June 28th 2024Charlie Borowicz, manager of trans and gender diverse health at Allegheny Health Network, shares how the program offers comprehensive patient-first care to those in the LGBTQ+ and gender diverse community.
Listen